Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26044 | 21168460 | J Hepatol | Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. | 2010 | Details |
| A26045 | 21168459 | J Hepatol | Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. | 2010 | Details |
| A26046 | 21168455 | J Hepatol | Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. | 2010 | Details |
| A26047 | 21168155 | J Pediatr | A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. | 2010 | Details |
| A26048 | 21167427 | Ann Pathol | [Hepatic lesions induced by systemic chemotherapy for digestive cancer]. | 2010 | Details |
| A26051 | 21166266 | Bull Mem Acad R Med Belg | Non-alcoholic fatty liver disease. | 2010 | Details |
| A26052 | 21162572 | J Agric Food Chem | Lipid fatty acid profile analyses in liver and serum in rats with nonalcoholic steatohepatitis using improved gas chromatography-mass spectrometry methodology. | 2010 | Details |
| A26053 | 21161009 | World J Hepatol | Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. | 2010 | Details |
| A26054 | 21160985 | World J Hepatol | Combination drug treatment in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26055 | 21160946 | World J Hepatol | Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. | 2010 | Details |
| A26056 | 21157426 | Int J Obes (Lond) | Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. | 2010 | Details |
| A26057 | 21155882 | J Gastroenterol Hepatol | Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A26058 | 21155004 | World J Gastroenterol | Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. | 2010 | Details |
| A26059 | 21153530 | Diabetologia | Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. | 2010 | Details |
| A26061 | 21150132 | Drug Metab Pharmacokinet | Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. | 2010 | Details |
| A26062 | 21147505 | J Hepatol | Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. | 2010 | Details |
| A26063 | 21147154 | Prev Med | Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. | 2010 | Details |
| A26064 | 21145868 | J Hepatol | Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. | 2010 | Details |
| A26065 | 21145857 | J Hepatol | New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. | 2010 | Details |
| A26066 | 21145850 | J Hepatol | Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? | 2010 | Details |
| A26067 | 21145844 | J Hepatol | Endoplasmic reticulum stress in liver disease. | 2010 | Details |
| A26068 | 21145841 | J Hepatol | Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. | 2010 | Details |
| A26069 | 21145840 | J Hepatol | The heart in liver transplantation. | 2010 | Details |
| A26070 | 21145833 | J Hepatol | Direct effects of iodothyronines on excess fat storage in rat hepatocytes. | 2010 | Details |
| A26071 | 21145829 | J Hepatol | Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. | 2010 | Details |
| A26072 | 21145828 | J Hepatol | A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. | 2010 | Details |
| A26073 | 21145823 | J Hepatol | Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. | 2010 | Details |
| A26074 | 21145819 | J Hepatol | Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. | 2010 | Details |
| A26076 | 21145805 | J Hepatol | An apoptosis panel for nonalcoholic steatohepatitis diagnosis. | 2011 | Details |
| A26077 | 21143008 | Clin Chem Lab Med | Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. | 2010 | Details |
| A26078 | 21139538 | Minerva Gastroenterol Dietol | [Non-alcoholic hepatic steatosis: the role of policosanols in associated hyperlipidemia]. | 2010 | Details |
| A26080 | 21115577 | Oncologist | The etiology of hepatocellular carcinoma and consequences for treatment. | 2010 | Details |
| A26081 | 21137056 | Proteomics Clin Appl | Non-alcoholic fatty liver disease proteomics. | 2010 | Details |
| A26082 | 21134109 | Liver Int | Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. | 2010 | Details |
| A26083 | 21130626 | Arch Pediatr | [Nonalcoholic fatty liver disease in a severely obese adolescent. An arguable liver biopsy]. | 2010 | Details |
| A26084 | 21129376 | Gastroenterology | Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. | 2010 | Details |
| A26085 | 21128705 | Antioxid Redox Signal | Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. | 2011 | Details |
| A26086 | 21128245 | Int J Cancer | Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. | 2011 | Details |
| A26087 | 21126940 | Environ Health Perspect | Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. | 2010 | Details |
| A26088 | 21126792 | J Hepatol | Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26089 | 21126079 | J Agric Food Chem | Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. | 2010 | Details |
| A26090 | 21122807 | Toxicol Appl Pharmacol | Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. | 2010 | Details |
| A26091 | 21119613 | Nat Rev Gastroenterol Hepatol | Animal models of nonalcoholic fatty liver disease. | 2010 | Details |
| A26092 | 21118396 | Aliment Pharmacol Ther | Alcohol consumption appears to protect against non-alcoholic fatty liver disease. | 2010 | Details |
| A26093 | 21115542 | Gut | Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis. | 2010 | Details |
| A26094 | 21114362 | Physiol Res | The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats. | 2010 | Details |
| A26095 | 26190482 | Clin J Gastroenterol | The latest idea in NAFLD/NASH pathogenesis. | 2010 | Details |
| A26097 | 21109326 | J Hepatol | Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. | 2010 | Details |
| A26098 | 21109302 | Lancet | Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. | 2010 | Details |
| A26099 | 21108736 | Liver Int | Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? | 2010 | Details |
| A26100 | 21106424 | Ann Diagn Pathol | Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. | 2010 | Details |
| A26102 | 21097793 | Arch Dis Child | Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic. | 2010 | Details |
| A26104 | 21091933 | J Dig Dis | Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. | 2011 | Details |
| A26105 | 21091931 | J Dig Dis | Epidemiology of the metabolic syndrome in the USA. | 2011 | Details |
| A26106 | 21091060 | Metab Syndr Relat Disord | Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. | 2010 | Details |
| A26107 | 21090330 | Zhen Ci Yan Jiu | [Effect of electroacupuncture on hypothalamic leptin and leptin receptor mRNA expression in rats with nonalcoholic fatty liver disease]. | 2010 | Details |
| A26108 | 21084751 | J Clin Invest | Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. | 2010 | Details |
| A26109 | 21079772 | PLoS One | Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice. | 2010 | Details |
| A26110 | 21077793 | Clin Chem Lab Med | Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26111 | 21077292 | Rinsho Byori | [Chronic liver disease related to impaired glucose tolerance]. | 2010 | Details |
| A26112 | 21075404 | Metabolism | Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. | 2010 | Details |
| A26113 | 21073649 | Liver Int | Angiogenesis in chronic liver disease and its complications. | 2010 | Details |
| A26114 | 21073123 | J Pediatr Endocrinol Metab | Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease. | 2010 | Details |
| A26115 | 21073069 | Southeast Asian J Trop Med Public Health | Prevalence of non-alcoholic fatty liver in a hypercholesterolemic population of northwestern peninsular Malaysia. | 2010 | Details |
| A26116 | 21072891 | World J Gastroenterol | Histopathology of nonalcoholic fatty liver disease. | 2010 | Details |
| A26117 | 21072890 | World J Gastroenterol | Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology. | 2010 | Details |
| A26118 | 21071306 | Orv Hetil | [Fatty liver and global cardiometabolic risk]. | 2010 | Details |
| A26119 | 21071305 | Orv Hetil | [Non-alcoholic steatosis/steatohepatitis -- 2010]. | 2010 | Details |
| A26120 | 21068129 | Gut | Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. | 2010 | Details |
| A26121 | 21067942 | Trends Endocrinol Metab | Fructose induced lipogenesis: from sugar to fat to insulin resistance. | 2010 | Details |
| A26122 | 21059296 | Zhonghua Gan Zang Bing Za Zhi | [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD]. | 2010 | Details |
| A26123 | 21057163 | Ann Hepatol | G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients. | 2011 | Details |
| A26124 | 21057159 | Ann Hepatol | Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. | 2011 | Details |
| A26125 | 21057158 | Ann Hepatol | Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis. | 2011 | Details |
| A26126 | 21055684 | Clin Liver Dis | Nonalcoholic fatty liver disease. | 2010 | Details |
| A26127 | 21054523 | J Gastroenterol Hepatol | Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. | 2011 | Details |
| A26128 | 21054517 | J Gastroenterol Hepatol | Sophocarpine alleviates non-alcoholic steatohepatitis in rats. | 2011 | Details |
| A26129 | 21050233 | Aliment Pharmacol Ther | A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. | 2010 | Details |
| A26130 | 21047423 | Diabetol Metab Syndr | Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. | 2010 | Details |
| A26131 | 21045794 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in nonalcoholic fatty liver disease. | 2010 | Details |
| A26132 | 21044019 | Curr Vasc Pharmacol | Ezetimibe; more than a low density lipoprotein cholesterol lowering drug? An update after 4 years. | 2011 | Details |
| A26133 | 21044016 | Curr Vasc Pharmacol | Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment. | 2011 | Details |
| A26134 | 21042922 | J Gastroenterol | The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. | 2010 | Details |
| A26135 | 21042596 | PLoS One | Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. | 2010 | Details |
| A26136 | 21042270 | Minerva Pediatr | [Pediatric non-alcoholic fatty liver disease: recent advances and challenges]. | 2010 | Details |
| A26137 | 21042023 | Digestion | Obesity affects the liver - the link between adipocytes and hepatocytes. | 2010 | Details |
| A26138 | 21040936 | Metabolism | The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study). | 2010 | Details |
| A26139 | 21040935 | Metabolism | Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2010 | Details |
| A26140 | 21040407 | Liver Int | Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. | 2010 | Details |
| A26141 | 21039302 | Ann Med | Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. | 2010 | Details |
| A26142 | 21037547 | Minerva Gastroenterol Dietol | Metabolic syndrome and liver transplantation. | 2010 | Details |
| A26147 | 21033090 | Eksp Klin Gastroenterol | [Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis]. | 2010 | Details |
| A26148 | 21033089 | Eksp Klin Gastroenterol | [Thyroid dysfunction and soft fatty liver disease]. | 2010 | Details |
| A26149 | 21033087 | Eksp Klin Gastroenterol | [Obesity in childhood]. | 2010 | Details |
| A26150 | 21033082 | Eksp Klin Gastroenterol | [Taurine in the treatment of non-alcoholic fatty liver disease]. | 2010 | Details |
| A26151 | 21033081 | Eksp Klin Gastroenterol | [Diagnostic value of nitric oxide and endotoxins at non-alcoholic fatty liver disease]. | 2010 | Details |
| A26152 | 21033080 | Eksp Klin Gastroenterol | [Hypolipidemic therapy in patients with non-alcoholic fatty liver disease]. | 2010 | Details |
| A26153 | 21033079 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease as an atherosclerosis risk factor]. | 2010 | Details |
| A26154 | 23051943 | Indian J Med Sci | Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance. | 2010 | Details |
| A26155 | 21030787 | Exp Anim | Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. | 2010 | Details |